Friday, 21 November 2008 | 23:04

Home Liver Disease & Hepatitis

Title: Find out about possible liver damage using Fibroscan Technology in Bangkok, Thailand User Rating: / 0 Wednesday, 30 July 2008 The liver is the largest organ in your body and carries out many vital functions. Its responsibilities are, or instance, digesting proteins and fats, removing toxins from your body, producing chemicals that stop the blood from clotting, and releasing bile in order to aid digestion. Read more...   Hepatitis C- What You Should Know About This Virus! User Rating: / 0 Tuesday, 13 May 2008 Most people across the globe are not well informed about Hepatitis C. No wonder, why they are attacked by this infectious virus, once in their life time. Hepatitis C can also be referred to as the type of Hepatitis that shows symptoms alike to the flu. Read more...   Researchers Identify Treatment Target For Liver Cancer Recurrence And Survival User Rating: / 0 Friday, 11 April 2008 Deadly and hard to treat, liver cancer has long resisted attempts by researchers to develop ways to prolong life and prevent recurrence. Read more...   Antipodean Pharmaceuticals Announces Completion Of Phase 2 Study Of Lead Compound MitoQ(R) User Rating: / 0 Friday, 11 April 2008 Antipodean Pharmaceuticals, Inc. announced that it has completed its Phase 2 study of its lead compound, MitoQ(R) (mitoquinone) in liver disease. Read more...   Hepatitis B Virus Triggers Cell 'Suicide' In Patients With Chronic Infection User Rating: / 0 Wednesday, 09 April 2008 Scientists from UCL (University College London) have identified a key difference between people who can fight the Hepatitis B virus (HBV) off successfully and those who fail to do so - that a group of cells weighty in controlling the disease are triggered to 'commit suicide' in patients who are... Read more...   Roche Diagnostics Expands Availability Of Hepatitis C Virus (HCV) Immunoassay User Rating: / 0 Wednesday, 09 April 2008 Roche Diagnostics announced that the Elecsys Anti-HCV (Hepatitis C Virus) assay has received regulatory approval in Europe for the E 170 analyzer for MODULAR ANALYTICS and the e 601 module for the cobas 6000 platform. Read more...   For Patients With Advanced Liver Cancer, Hope Found In Combination Therapy User Rating: / 0 Tuesday, 08 April 2008 By combining one type of chemotherapy with another radiothermal therapy, medical scientists were able to enhance the survival time for patients with improved liver cancer in comparison to each therapy alone, according to a study published on April 9, 2008 in JAMA. Read more...   Pegintron(TM) Plus Weight-Based Rebetol(R) Resulted In Higher SVR Than Flat Dosing; Low Relapse Rate User Rating: / 0 Friday, 28 March 2008 Read more...   Lifetime Effects Of Pediatric Liver Transplants User Rating: / 0 Thursday, 27 March 2008 Parents of pediatric liver transplant recipients report lower health-related quality of life for their children 2 years after the surgery, compared to reports from the parents of healthful children. However, reports of family dysfunction fall within the normal range. Read more...   BARACLUDE Data Show Low Resistance Over 5 Years In Nucleoside-Naive Hepatitis B Patients User Rating: / 0 Tuesday, 25 March 2008 New BARACLUDE® (entecavir) data presented 24th March demonstrated a continued low incidence of resistance in nucleoside-naive patients through five years of treatment. In the nucleoside-naive chronic hepatitis B patients analyzed, no additional patient developed resistance in the fifth year (n=108). Read more...   Dramatic Rise In Hepatitis C-Related Deaths In The United States With Greatest Risk To Middle-Aged P User Rating: / 0 Tuesday, 25 March 2008 Hepatitis C-related deaths in the United States increased by 123 percent from 1995 through 2004, the most recent year for which data are available. Mortality rates peaked in 2002, then declined somewhat overall, while continuing to rise among people 55 to 64 years old. Read more...   Baraclude(R) Data Continue To Demonstrate Low Incidence Of Resistance Through 5 Years Of Treatment I User Rating: / 0 Tuesday, 25 March 2008 New BARACLUDE(R) (entecavir) data presented demonstrated a continued low incidence of resistance in nucleoside-naïve patients through five years of treatment. In the nucleoside-naïve chronic hepatitis B patients analyzed, no additional patient developed resistance in the fifth year (n=108). Read more...   BARACLUDE(R) Data Continue To Demonstrate Low Incidence Of Resistance Through Five Years Of Treatmen User Rating: / 0 Tuesday, 25 March 2008 New BARACLUDE(R) (entecavir) data presented demonstrated a continued low incidence of resistance in nucleoside-naive patients through five years of treatment. In the nucleoside-naive chronic hepatitis B patients analyzed, no additional patient developed resistance in the fifth year (n=108). Read more...   Process Discovered To Disrupt Hepatitis C Virion Production User Rating: / 0 Monday, 24 March 2008 HCV is a essential human pathogen, infecting more than 3 percent of the world's population. The incidence of infection in the United States has been estimated to be as high as 4 million cases. Read more...   Hepatitis B Foundation Testifies Before Congressional Appropriation Committee And Urges More Federal User Rating: / 0 Saturday, 22 March 2008 Hepatitis B Foundation President Dr. Read more...   European CHMP Issues Positive Opinion For Viread® For The Treatment Of Chronic Hepatitis B User Rating: / 0 Friday, 21 March 2008 Gilead Sciences, Inc. Read more...   Living Donor Liver Transplants Improved Outcome Using New Technique User Rating: / 0 Wednesday, 19 March 2008 The University of Alberta Hospital (UAH) is one of only a few centers in Canada that perform living donor liver transplantation, a surgical procedure developed in the late 1980s that expands the organ donor pool. About 80 liver transplants are done a year in Alberta, 10 of those being living-donor. Read more...   Possible New Treatment Strategy For Muscular Dystrophy User Rating: / 0 Tuesday, 18 March 2008 An investigational antiviral drug presently undergoing human trials in Europe for treating Hepatitis C infections may have potential to decrease muscle cell damage in Duchenne and other forms of muscular dystrophy (MD). Read more...   A New Finding In Liver Transplantation And Antifibrinolytics? User Rating: / 0 Friday, 14 March 2008 Orthotopic liver transplantation (OLT) is associated with severe bleeding and considerable transfusion requirements. There are several reasons for this severe bleeding in OLT. Hemostatic abnormalities stay a major cause. Read more...   Stenting And Photodynamic Combined Therapy Improves Survival In Late Stage Liver Cancer Patients User Rating: / 0 Wednesday, 12 March 2008 A combined therapeutic approach of stenting and photodynamic therapy may advance survival rates for patients suffering from enhanced liver bile duct cancer, according to a study published this month in Clinical Gastroenterology and Hepatology, the official journal of the American... Read more...   Progen Announces Commencement Of Global Phase 3 Study For PI 88 In Post Resection Liver Cancer User Rating: / 0 Wednesday, 12 March 2008 Progen Pharmaceuticals Limited (ASX: PGL; Nasdaq: PGLA) announced the commencement of its global phase 3 study investigating PI-88 as an adjuvant treatment for primary liver cancer (hepatocellular carcinoma, HCC) following curative resection with the first patient having been randomized onto the... Read more...   Hepatitis E Virus Research Goal Is The Development Of Human, Animal Vaccine User Rating: / 0 Monday, 10 March 2008 Read more...   Massive Las Vegas Hepatitis C Scare Causes Public Health Crisis - Edward M. Bernstein & Associates F User Rating: / 0 Thursday, 06 March 2008 Edward M. Bernstein & Associates, one of Nevada's leading Personal Injury Law Firms has been retained by former patients of the Endoscopy Center of Southern Nevada, who have actually, tested positive for a Hepatitis C Infection in Las Vegas. Read more...   Alcoholic Fatty Liver And Cannabinoid-Blocking Weight-Loss Drug User Rating: / 0 Wednesday, 05 March 2008 The cannabinoid receptors best known for delivering the psychological effects of marijuana also clarify the connection between chronic alcohol use and a buildup of fat in the liver, according to a report in the March issue of Cell Metabolism, a publication of Cell Press. Read more...   Portopulmonary Hypertension May Be Treated By A Combination Therapy Of 3 Vasodilators User Rating: / 0 Wednesday, 05 March 2008 Combination therapy of Prostacyclin, Sildenafil, and Bosentan helped a young male patient with severe portopulmonary hypertension enhance enough to receive a liver transplant. It was also used post-transplant to help him maintain his health. Read more...   Potentially Life-Threatening Conditions Revealed By Elevated Liver Enzymes User Rating: / 0 Tuesday, 04 March 2008 A new population-based epidemiological study has found that elevated liver enzymes discovered during routine medical care are associated with higher future mortality. Read more...   In Patients With Advanced Chronic Hepatitis C - Serum Fibrosis Markers Correlate With Liver Fibrosis User Rating: / 0 Tuesday, 04 March 2008 A prospective study of patients with improved chronic hepatitis C (CHC) revealed that a 3-variable model of serum fibrosis markers, including serum HA, TIMP-1 and platelet count, could identify cirrhosis with better accuracy than other published models. Read more...   Las Vegas Clinic Shut After Hepatitis C Infections User Rating: / 0 Tuesday, 04 March 2008 The City of Las Vegas shut down a clinic last week after health officials traced several cases of hepatitis C to the endoscopy centre. Read more...   The Cause Of Effectiveness Has Been Discovered For A Cirrhosis Treatment That Has Been Shown To Be U User Rating: / 0 Friday, 29 February 2008 Scientists of the Center for Applied Medical Research (CIMA) of the University of Navarra have discovered the molecular mechanism responsible for the effectiveness of an existing treatment for primary biliary cirrhosis, which combines 2 substances in order to make an effect that does not result... Read more...   Idenix Announces Data Presentations At The 43rd Annual Meeting Of The European Association For The S User Rating: / 0 Tuesday, 26 February 2008 Idenix Pharmaceuticals, Inc. Read more...

<< Start < Prev 1 2 Next > End >>

Results 1 - 30 of 60